Quoin Pharmaceuticals (QNRX) to Release Earnings on Thursday

Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, May 9th.

Quoin Pharmaceuticals (NASDAQ:QNRX) last issued its earnings results on Wednesday, March 13th. The company reported ($2.08) EPS for the quarter, topping analysts’ consensus estimates of ($2.37) by $0.29.

Quoin Pharmaceuticals Stock Up 3.2 %

Shares of NASDAQ:QNRX opened at $0.77 on Wednesday. The stock has a market cap of $2.84 million, a PE ratio of -0.08 and a beta of 1.85. The company’s fifty day moving average is $1.02 and its 200 day moving average is $3.02. Quoin Pharmaceuticals has a 52 week low of $0.60 and a 52 week high of $12.00.

Analyst Upgrades and Downgrades

Separately, Maxim Group decreased their target price on shares of Quoin Pharmaceuticals from $15.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, March 15th.

Quoin Pharmaceuticals Company Profile

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.